Strata Critical Medical (SRTA) Change in Accured Expenses (2019 - 2026)

Strata Critical Medical (SRTA) has 8 years of Change in Accured Expenses data on file, last reported at -$2.2 million in Q1 2026.

• Change in Accured Expenses for Q1 2026 came in at -$2.2 million, up 5.27% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.5 million (up 759.1% YoY), and the FY2025 annual result was $2.4 million, up 128.52% from the prior year.
• Change in Accured Expenses fell to -$2.2 million in Q1 2026 per SRTA's latest filing, from $795000.0 in the prior quarter.
• Over five years, Change in Accured Expenses peaked at $5.0 million in Q4 2023 and troughed at -$10.2 million in Q1 2024.
• A 5-year average of $322800.0 and a median of $795000.0 in 2025 frame the typical range for Change in Accured Expenses.
• The sharpest annual moves came in 2023 and 2025: Change in Accured Expenses plunged 228.34% in 2023, then jumped 39850.0% in 2025.
• A 5-year view of Change in Accured Expenses shows it stood at $1.3 million in 2022, then jumped by 289.25% to $5.0 million in 2023, then plunged by 100.04% to -$2000.0 in 2024, then jumped by 39850.0% to $795000.0 in 2025, then tumbled by 371.45% to -$2.2 million in 2026.
• Business Quant data shows SRTA's Change in Accured Expenses at -$2.2 million in Q1 2026, $795000.0 in Q4 2025, and $669000.0 in Q3 2025.